Virpax Pharmaceuticals Inc. (NASDAQ: VRPX)
$0.3660
+0.0004 ( -4.96% ) 593.7K
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Market Data
Open
$0.3660
Previous close
$0.3656
Volume
593.7K
Market cap
$5.44M
Day range
$0.3510 - $0.3940
52 week range
$0.2860 - $5.4800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | May 13, 2024 |
| 10-q | Quarterly Reports | 54 | May 13, 2024 |
| 8-k | 8K-related | 14 | May 02, 2024 |
| 8-k | 8K-related | 15 | Apr 30, 2024 |
| 8-k | 8K-related | 13 | Apr 03, 2024 |
| 10-k | Annual reports | 76 | Mar 26, 2024 |
| 8-k | 8K-related | 15 | Mar 26, 2024 |
| 8-k | 8K-related | 13 | Mar 18, 2024 |
| 8-k | 8K-related | 17 | Mar 01, 2024 |
| 4 | Insider transactions | 2 | Jan 31, 2024 |